These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
328 related articles for article (PubMed ID: 29628309)
1. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex. Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309 [TBL] [Abstract][Full Text] [Related]
2. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis. Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101 [TBL] [Abstract][Full Text] [Related]
3. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336 [TBL] [Abstract][Full Text] [Related]
4. Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program. Tan Y; Jin C; Ma W; Hu Y; Tanasa B; Oh S; Gamliel A; Ma Q; Yao L; Zhang J; Ohgi K; Liu W; Aggarwal AK; Rosenfeld MG Mol Cell; 2018 Aug; 71(4):526-539.e8. PubMed ID: 30118678 [TBL] [Abstract][Full Text] [Related]
5. JMJD6 regulates ERα methylation on arginine. Poulard C; Rambaud J; Hussein N; Corbo L; Le Romancer M PLoS One; 2014; 9(2):e87982. PubMed ID: 24498420 [TBL] [Abstract][Full Text] [Related]
6. PELP1 oncogenic functions involve CARM1 regulation. Mann M; Cortez V; Vadlamudi R Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015 [TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program. Yang F; Ma Q; Liu Z; Li W; Tan Y; Jin C; Ma W; Hu Y; Shen J; Ohgi KA; Telese F; Liu W; Rosenfeld MG Mol Cell; 2017 May; 66(3):321-331.e6. PubMed ID: 28475868 [TBL] [Abstract][Full Text] [Related]
8. Novel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-α. Purcell DJ; Chauhan S; Jimenez-Stinson D; Elliott KR; Tsewang TD; Lee YH; Marples B; Lee DY Mol Endocrinol; 2015 Dec; 29(12):1708-19. PubMed ID: 26505218 [TBL] [Abstract][Full Text] [Related]
12. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Frietze S; Lupien M; Silver PA; Brown M Cancer Res; 2008 Jan; 68(1):301-6. PubMed ID: 18172323 [TBL] [Abstract][Full Text] [Related]
13. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer. Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470 [TBL] [Abstract][Full Text] [Related]
14. LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP. Bennesch MA; Segala G; Wider D; Picard D Nucleic Acids Res; 2016 Oct; 44(18):8655-8670. PubMed ID: 27325688 [TBL] [Abstract][Full Text] [Related]
15. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Yang J; Jubb AM; Pike L; Buffa FM; Turley H; Baban D; Leek R; Gatter KC; Ragoussis J; Harris AL Cancer Res; 2010 Aug; 70(16):6456-66. PubMed ID: 20682797 [TBL] [Abstract][Full Text] [Related]
16. Cohesin is required for activation of MYC by estradiol. McEwan MV; Eccles MR; Horsfield JA PLoS One; 2012; 7(11):e49160. PubMed ID: 23145106 [TBL] [Abstract][Full Text] [Related]
17. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597 [TBL] [Abstract][Full Text] [Related]
18. JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells. Das P; Gupta A; Desai KV Front Endocrinol (Lausanne); 2022; 13():1028616. PubMed ID: 36419768 [TBL] [Abstract][Full Text] [Related]
19. Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release. Liu W; Ma Q; Wong K; Li W; Ohgi K; Zhang J; Aggarwal A; Rosenfeld MG Cell; 2013 Dec; 155(7):1581-1595. PubMed ID: 24360279 [TBL] [Abstract][Full Text] [Related]
20. Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor α via distinct mechanisms. Sun Y; Chung HH; Woo AR; Lin VC Biochim Biophys Acta; 2014 Sep; 1843(9):2067-78. PubMed ID: 24742914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]